We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $156M
1-Year Est. Return 14.89%
This Fund
S&P 500
This Quarter Est. Return
+1.04%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.09%
AUM
$873M
AUM Growth
-$174M
Cap. Flow
-$174M
Cap. Flow %
-19.94%
Top 10 Hldgs %
17.05%
Holding
1,175
New
428
Increased
111
Reduced
142
Closed
493

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$38M
2
TSLA icon
Tesla
TSLA
+$17.7M
3
ULTA icon
Ulta Beauty
ULTA
+$12M
4
ADBE icon
Adobe
ADBE
+$11.3M
5
SHOP icon
Shopify
SHOP
+$9.5M

Top Sells

Rank Stock Value
1
GM icon
General Motors
GM
+$12.5M
2
MU icon
Micron Technology
MU
+$11M
3
CSCO icon
Cisco
CSCO
+$10.9M
4
DELL icon
Dell
DELL
+$10.6M
5
FDX icon
FedEx
FDX
+$10.1M

Sector Composition

Rank Sector Weight
1 Technology 24.87%
2 Consumer Discretionary 15.2%
3 Industrials 10.77%
4 Healthcare 9.97%
5 Financials 9.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FWRG icon
876
First Watch Restaurant Group
FWRG
$764M
-19,369
Closed -$477K
G icon
877
Genpact
G
$6.31B
-42,146
Closed -$1.39M
GBX icon
878
The Greenbrier Companies
GBX
$1.43B
-6,328
Closed -$330K
GDRX icon
879
GoodRx Holdings
GDRX
$1.2B
-13,868
Closed -$98.5K
GES
880
DELISTED
Guess Inc
GES
-39,600
Closed -$1.25M
GEVO icon
881
Gevo
GEVO
$415M
-35,352
Closed -$27.2K
GIL icon
882
Gildan
GIL
$9.86B
-11,307
Closed -$420K
GILD icon
883
Gilead Sciences
GILD
$185B
-16,200
Closed -$1.19M
GIS icon
884
General Mills
GIS
$21.6B
-58,300
Closed -$4.08M
GLDD
885
DELISTED
Great Lakes Dredge & Dock
GLDD
-15,711
Closed -$137K
GMAB icon
886
Genmab
GMAB
$21B
-11,436
Closed -$342K
GNTX icon
887
Gentex
GNTX
$4.86B
-26,700
Closed -$964K
GO icon
888
Grocery Outlet
GO
$1.16B
-48,576
Closed -$1.4M
GOGL
889
DELISTED
Golden Ocean Group
GOGL
-11,624
Closed -$151K
GOOG icon
890
Alphabet (Google) Class C
GOOG
$4.13T
-42,185
Closed -$6.42M
GOOGL icon
891
Alphabet (Google) Class A
GOOGL
$4.17T
-51,490
Closed -$7.77M
GPCR icon
892
Structure Therapeutics
GPCR
$3.51B
-6,108
Closed -$262K
GPK icon
893
Graphic Packaging
GPK
$3.35B
-7,207
Closed -$210K
GS icon
894
Goldman Sachs
GS
$303B
-3,128
Closed -$1.31M
GTLB icon
895
GitLab
GTLB
$7.57B
-27,830
Closed -$1.62M
GTLS
896
DELISTED
Chart Industries
GTLS
-11,583
Closed -$1.91M
HAL icon
897
Halliburton
HAL
$29.6B
-9,500
Closed -$374K
HAYW icon
898
Hayward Holdings
HAYW
$3.02B
-62,200
Closed -$952K
HELE icon
899
Helen of Troy
HELE
$674M
-6,025
Closed -$694K
HL icon
900
Hecla Mining
HL
$14.4B
-91,800
Closed -$442K

Similar funds

Bayesian Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Bayesian Capital Management held 1,175 positions worth $873M, down 17% from $1.05B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Bayesian Capital Management withdrew a net $174M in Q2 2024, closing 493 positions and reducing 142 holdings. Its most notable exit was Micron Technology, an estimated $11M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Bayesian Capital Management opened a new position in State Street SPDR S&P 500 ETF Trust worth $39.5M.

  • Bayesian Capital Management's largest Q2 2024 buy was State Street SPDR S&P 500 ETF Trust: 72,600 shares worth $39.5M.
  • Bayesian Capital Management added most to Accenture in Q2 2024, an estimated $6.1M increase.
  • Bayesian Capital Management's biggest Q2 2024 reduction was General Motors, cutting an estimated $12.5M.
  • Bayesian Capital Management fully exited Micron Technology in Q2 2024, selling an estimated $11M.
  • Bayesian Capital Management's ten largest holdings make up 17% of its $873M portfolio in Q2 2024.
  • Bayesian Capital Management opened 428 new positions and closed 493 in Q2 2024.
  • Bayesian Capital Management's portfolio value fell 17% quarter-over-quarter to $873M.

Based on Bayesian Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.